泌尿外科由原副院长李德超创立于1980年，“排石”作为“禅医三宝”而家喻户晓。在李德超、詹河涓、郑彬三代学科带头人的带领下，以“建设和谐快乐的医患家园”为服务愿景，以“微创技术深入挖掘”为发展动力，大力培养中青年专家突破亚专业瓶颈，经过40年的努力建设成了以“尿石、肿瘤、前列腺、男科”为特色的品牌专科。二个住院病区，71张病床。2024年年门诊量近4万人次，年出院人数近5千人次，年住院手术近3千台。人才结构合理，主任医师5名，副主任医师3名，主治医师4名，住院医师1名，其中博士1名，硕士7名。现有一流的先进设备，包括Xi达芬奇手术机器人，科医人双子星激光系统和60W钬激光系统，奥林巴斯高清腹腔镜2套，前列腺剜除镜2套。在研的省市级科研立项多项，其中郑彬主持的经皮肾镜研究成果获得2011年度禅城区科技进步一等奖和2014年度佛山市科技进步二等奖。近年来连续主办国家级、省级、市级继续医学教育学习班，通过学习交流，推广应用新技术，不断提高禅医泌尿外科的学术地位，已发展成为集医疗、教学、科研为一体的在广东省具有较高学术地位的泌尿专科。
禅医泌尿外科在泌尿系结石亚专业方面处于佛山市领先地位，2003年开展经皮肾镜取石手术，累计手术量达到近3千多例，特别擅长治疗无积水鹿角形肾结石和复杂性肾结石；2015年率先开展电子输尿管软镜钬激光碎石，2022年开展输尿管软镜负压清石手术，累计手术量达到5千多例。常规开展体外冲击波碎石，常规应用中药辅助排石，常规开展结石成份分析，指导病人预防结石复发方面有丰富经验。每一位尿石病人在禅医均能得到合理有效的治疗。
2022年6月中山大学孙逸仙纪念医院泌尿外科主任黄健教授多点执业佛山禅医，黄健教授是中华医学会泌尿外科分会主任委员，擅长泌尿肿瘤的综合治疗，特别擅长膀胱恶性肿瘤的治疗，腹腔镜膀胱癌根治术+回肠原位新膀胱术名扬国内外，黄健教授执业佛山禅医后吸引了不少周边泌尿肿瘤患者前来禅医门诊就诊（隔周周六下午黄健教授在禅医开诊），开展了包括肾上腺、肾、前列腺、膀胱各种疑难复杂的机器人辅助下肿瘤根治手术。泌尿肿瘤专业常规开展MDT讨论，为每个病人提供个性化治疗方案，并进行全病程管理，为每一位病人提供优质合理医疗服务。目前达芬奇机器人团队已完成四级手术200多例，郑彬主任团队已熟练掌握保留性功能和控尿功能的膀胱癌根治+回肠原位新膀胱手术，郑彬主任团队机器人辅助下一体位肾盂癌根治术已做出特色，在2025年全国年会上交流。郑彬主任团队熟练掌握机器人辅助下前列腺癌根治术，术后即刻控尿和保留性功能方面已达到较高水平。郑彬主任团队机器人辅助下保留肾脏肾肿瘤切除方面也积累了丰富经验。
2015年在佛山市率先开展经尿道前列腺激光剜除术，以整叶法剜除为我科特色，将增生腺体剜除得更加彻底，排尿更顺畅，复发机会更少。目前正在开展前列腺热蒸汽消融治疗良性前列腺增生，为良性前列腺增生患者提供更多选择。
男科总体实力雄厚，有主任医师1名，主治医师2名，6张住院病床。在前列腺炎、男性功能、男性生育、排尿功能障碍、男性主动健康管理等亚专业有很强的实力，开展输精管与输精管吻合、输精管附睾显微镜下吻合，精索静脉显微镜下结扎，精索静脉与腹壁下静脉转流手术，精囊镜检查等手术。男科门诊专门设有电磁治疗、电生理治疗、电热场治疗、尿动力检查等。
The Department of Urology was founded in 1980 by former Vice President Dr. Li Dechao. “Stone Expulsion Therapy,” known locally as one of the “Three Treasures of Zen Medicine,” has become widely recognized by the public. Under the leadership of three successive discipline heads—Dr. Li Dechao, Dr. Zhan Hejuan, and Dr. Zheng Bin—the department has grown with the vision of building a harmonious and patient-centered healing environment and the mission of advancing minimally invasive technologies. Through dedicated training of young and mid-career specialists and by overcoming subspecialty barriers, the department has, over four decades, developed into a renowned specialty service focusing on urinary stone disease, urologic oncology, prostate disease, and andrology.
The department operates two inpatient wards with 71 beds. In 2024, annual outpatient visits approached 40,000, inpatient discharges nearly 5,000, and surgical volume exceeded 3,000 procedures. The team has an optimized talent structure, including 5 chief physicians, 3 associate chief physicians, 4 attending physicians, and 1 resident, among whom 1 holds a PhD and 7 hold Master’s degrees.
The department is equipped with state-of-the-art technology, including the da Vinci Xi surgical robot, the Lumenis Soltive™ laser platform, a 60-W holmium laser system, two Olympus HD laparoscopic suites, and two prostate enucleation endoscope systems. Multiple provincial and municipal research projects are currently in progress; notably, research led by Dr. Zheng Bin on percutaneous nephrolithotomy (PCNL) received the First Prize of Science and Technology Progress in Chancheng District (2011) and the Second Prize of Science and Technology Progress in Foshan City (2014).
The department has organized numerous national, provincial, and municipal continuing medical education programs in recent years, promoting new technologies and strengthening academic collaboration. It has evolved into a leading center in Guangdong Province that integrates clinical care, teaching, and scientific research.
The department is a regional leader in treating urinary stone disease.
PCNL was introduced in 2003, with a cumulative procedural volume exceeding 3,000 cases, with particular expertise in non-hydronephrotic staghorn stones and complex renal calculi.
In 2015, the department pioneered the use of digital flexible ureteroscopy with holmium laser lithotripsy.
In 2022, it launched negative-pressure suction-assisted flexible ureteroscopic lithotripsy, reaching a cumulative volume of over 5,000 cases.
Routine services include extracorporeal shockwave lithotripsy (ESWL), traditional Chinese medicine–assisted stone expulsion, and comprehensive stone composition analysis. The department has extensive experience in guiding patients in stone-recurrence prevention. Every patient with urinary stones receives individualized and effective treatment.
In June 2022, Professor Huang Jian, Chair of the Urology Branch of the Chinese Medical Association and Director of Urology at Sun Yat-sen Memorial Hospital, joined Foshan Zen Hospital as a multi-site senior consultant. Prof. Huang specializes in comprehensive management of urologic tumors and is internationally recognized for radical cystectomy with orthotopic ileal neobladder reconstruction via laparoscopic and robotic approaches. His practice in Foshan has attracted many regional oncology patients (he consults every other Saturday afternoon).
The department now routinely performs complex robotic oncologic surgeries involving the adrenal gland, kidney, prostate, and bladder.
A formal MDT (multidisciplinary team) process ensures personalized treatment plans and whole-course disease management for every cancer patient.
The da Vinci robotic surgery team has completed over 200 high-level robotic procedures.
Dr. Zheng Bin’s team has mastered nerve-sparing, continence-preserving robotic radical cystectomy with orthotopic ileal neobladder, and their robotic single-position nephroureterectomy has become a signature technique, to be presented at the 2025 National Annual Meeting.
The team also excels in robotic radical prostatectomy, achieving excellent outcomes in immediate continence recovery and functional preservation.
Extensive experience has also been accumulated in robotic nephron-sparing surgery for renal tumors.
In 2015, the department was the first in Foshan to perform transurethral laser enucleation of the prostate, using a full-lobe enucleation technique that enables more complete adenoma removal, smoother urination, and reduced recurrence. The department is also developing rezum water-vapor thermal therapy to offer additional minimally invasive options for benign prostatic hyperplasia (BPH).
The Andrology Unit is highly specialized, staffed by 1 chief physician, 2 attending physicians, and a 6-bed inpatient area. It provides strong expertise in:
prostatitis,
male sexual dysfunction,
male infertility,
voiding dysfunction,
and proactive male health management.
Surgical procedures include vasovasostomy, microsurgical vasoepididymostomy, microsurgical varicocele ligation, varicocele–inferior epigastric vein bypass, and seminal vesiculoscopy. The clinic offers dedicated services such as electromagnetic therapy, electrophysiological therapy, thermotherapy, and urodynamic testing.
